Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi

被引：67

作者：

Merli, Francesco ^{[1
]}

Luminari, Stefano ^{[2
]}

Rossi, Giuseppe ^{[3
]}

Mammi, Caterina ^{[1
]}

Marcheselli, Luigi ^{[2
]}

Ferrari, Angela ^{[1
]}

Spina, Michele ^{[4
]}

Tucci, Alessandra ^{[3
]}

Stelitano, Caterina ^{[5
]}

Capodanno, Isabella ^{[1
]}

Fragasso, Alberto ^{[6
]}

Baldini, Luca ^{[7
]}

Bottelli, Chiara ^{[3
]}

Montechiarello, Elisa ^{[5
]}

Fogazzi, Stefano ^{[3
]}

Lamorgese, Cinzia ^{[3
]}

Cavalli, Lara ^{[3
]}

Federico, Massimo ^{[2
]}

机构：

[1] Arcispedale Santa Maria Nuova, Hematol Unit, Ist Ricovero & Cura Carattere Sci, I-42123 Reggio Emilia, Italy

[2] Univ Modena & Reggio Emilia, Dept Hematol & Oncol, Modena, Italy

[3] Spedali Civil Brescia, Div Hematol, I-25125 Brescia, Italy

[4] Natl Canc Inst, Div Med Oncol A, Aviano, Italy

[5] Azienda Osped Bianchi Melacrino Morelli, Dept Hematol, Reggio Di Calabria, Italy

[6] Osped Madonna Grazie, Hematol Unit, Dept Internal Med, Matera, Italy

[7] Univ Milan, Ca Granda Hosp Maggiore Policlin, IRCCS Fdn, Hematol Unit 1, Milan, Italy

来源：

LEUKEMIA & LYMPHOMA | 2014年 / 55卷 / 01期

关键词：

Diffuse large B-cell lymphoma (DLBCL); elderly patients; frail patients; Comprehensive Geriatric Assessment (CGA); chemotherapy; rituximab; NON-HODGKINS-LYMPHOMA; TRIAL; CHEMOTHERAPY; RITUXIMAB; DOXORUBICIN; CANCER; CHOP; MANAGEMENT; RICOVER-60;

D O I：

10.3109/10428194.2013.788176

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In 2003 the Fondazione Italiana Linfomi (FIL) started a clinical research program for investigating initial treatment of frail elderly patients with diffuse large B-cell lymphoma (DLBCL) identified by Comprehensive Geriatric Assessment (CGA). From 2003 to 2006, 334 elderly patients underwent CGA assessment, and 99 patients were classified as frail. Frail patients had a median age of 78 years, stage III-IV disease in 62% and age-adjusted International Prognostic Index (aaIPI) of 2-3 in 53%. Treatment consisted of several different regimens according to physician discretion. After a median follow-up of 36 months, 5-year overall survival (OS) was 28%. In multivariate analysis, aaIPI 2-3 (p=0.005) and the presence of respiratory comorbidity (p=0.044) were the only factors that showed independent correlation with OS. Frail patients had a poorer outcome compared with fit patients also if they were treated with rituximab-containing combination chemotherapy (hazard ratio 2.37, 95% confidence interval 1.48-3.78; p<0.001). CGA is a valid tool to prospectively identify frail subjects among elderly patients with DLBCL.

引用

页码：38 / 43

页数：6

共 50 条

[21] OUTCOME OF AUTOLOGOUS TRANSPLANT IN "FIT" ELDERLY PATIENTS WITH RELAPSED/REFRACTORY AGGRESSIVE B LYMPHOMA: RESULTS OF THE PROSPECTIVE RECANZ STUDY BY THE "FONDAZIONE ITALIANA LINFOMI
Pagani, C.
Musuraca, G.
Cavallo, F.
Zilioli, V. R.
Zanni, M.
Pelliccia, S.
Mannina, D.
Michieli, M.
Vallisa, D.
Tani, M.
Merli, F.
Re, F.
Marcheselli, L.
Campostrini, G.
Grimaldi, D.
Liardo, E. V.
Re, A.
Cox, M. C.
Rossi, G.
Tucci, A.
HAEMATOLOGICA, 2021, 106 (10) : 70 - 70
[22] Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the Fondazione Italiana Linfomi
Storti, Sergio
Spina, Michele
Pesce, Emanuela Anna
Salvi, Flavia
Merli, Michele
Ruffini, Alessia
Cabras, Giuseppina
Chiappella, Annalisa
Angelucci, Emanuele
Fabbri, Alberto
Liberati, Anna Marina
Tani, Monica
Musuraca, Gerardo
Molinari, Annalia
Petrilli, Maria Pia
Palladino, Carmela
Ciancia, Rosanna
Ferrario, Andrea
Gasbarrino, Cristiana
Monaco, Federico
Fraticelli, Vincenzo
De Vellis, Annalisa
Merli, Francesco
Luminari, Stefano
HAEMATOLOGICA, 2018, 103 (08) : 1345 - 1350
[23] Comparison between R-COMP and R-CHOP in Older Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Substudy of the Elderly Project By the Fondazione Italiana Linfomi
Merli, Francesco
Spina, Michele
Tucci, Alessandra
Rigacci, Luigi
Cavallo, Federica
Cabras, Maria Giuseppina
Alvarez, Isabel
Fabbri, Alberto
Re, Alessandro
Puccini, Benedetta
Ferrero, Simone
Usai, Sara Veronica
Ferrari, Angela
Cencini, Emanuele
Pennese, Elsa
Zilioli, Vittorio Ruggero
Marino, Dario
Balzarotti, Monica
Cox, M. Christina
Zanni, Manuela
Di Rocco, Alice
Lleshi, Arben
Botto, Barbara
Hohaus, Stefan
Merli, Michele
Sartori, Roberto
Gini, Guido
Nassi, Luca
Musuraca, Gerardo
Tani, Monica
Bottelli, Chiara
Kovalchuk, Sofia
Re, Francesca
Flenghi, Leonardo
Molinari, Anna Lia
Tarantini, Giuseppe
Chimienti, Emanuela
Marcheselli, Luigi
Mammi, Caterina
Luminari, Stefano
Arcari, Annalisa
BLOOD, 2021, 138
[24] R-CHOP21 VS R-CHOP14 IN 1024 DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: RESULTS FROM A MULTICENTRE RETROSPECTIVE STUDY OF FONDAZIONE ITALIANA LINFOMI (FIL)
Rigacci, L.
Puccini, B.
Cabras, M. Giuseppina
Fabbri, A.
Nassi, L.
Musura-ca, G.
Mamusa, A.
Franceschetti, S.
Orciuolo, E.
Lucchesi, A.
Finolezzi, E.
Gandolfi, S.
Chiappella, A.
Spina, M.
Pietrini, A.
Dessi, D.
Ghio, F.
Fabbri, F.
Di Rocco, A.
Balzarotti, M.
Gaidano, G.
Martelli, M.
Vitolo, U.
Bosi, A.
HAEMATOLOGICA, 2013, 98 : 130 - 130
[25] The performance of abbreviated comprehensive geriatric assessment in elderly patients with diffuse large B cell lymphoma
Hung, Yu-Shin
Chang, Hung
Kuo, Ming-Chung
Chou, Wen-Chi
SUPPORTIVE CARE IN CANCER, 2025, 33 (02)
[26] Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma
Hanno M. Witte
Armin Riecke
Thomas Mayer
Tobias Bartscht
Dirk Rades
Hendrik Lehnert
Hartmut Merz
Sebastian Fetscher
Harald Biersack
Niklas Gebauer
Journal of Cancer Research and Clinical Oncology, 2019, 145 : 129 - 136
[27] Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma
Witte, Hanno M.
Riecke, Armin
Mayer, Thomas
Bartscht, Tobias
Rades, Dirk
Lehnert, Hendrik
Merz, Hartmut
Fetscher, Sebastian
Biersack, Harald
Gebauer, Niklas
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (01) : 129 - 136
[28] Comprehensive geriatric assessment as a useful tool in predicting adverse events in elderly patients with diffuse large B-cell lymphoma
Toshihiro Tanaka
Rika Sakai
Ilseung Choi
Junichi Tsukada
Hidenori Sasaki
Yoshiko Naito
Fumiaki Kiyomi
Yasushi Takamatsu
Kazuo Tamura
Scientific Reports, 12
[29] Comprehensive geriatric assessment as a useful tool in predicting adverse events in elderly patients with diffuse large B-cell lymphoma
Tanaka, Toshihiro
Sakai, Rika
Choi, Ilseung
Tsukada, Junichi
Sasaki, Hidenori
Naito, Yoshiko
Kiyomi, Fumiaki
Takamatsu, Yasushi
Tamura, Kazuo
SCIENTIFIC REPORTS, 2022, 12 (01)
[30] A SIMPLIFIED GERIATRIC ASSESSMENT CAN BE APPLIED TO GUIDE TREATMENT DECISIONS IN LATE-OCTOGENARIAN (LO) PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA (DLBCL). AN ANALYSIS OF 370 PATIENTS OF THE "ELDERLY PROJECT" BY THE FONDAZIONE ITALIANA LINFOMI (FIL)
Pagani, C.
Merli, F.
Fabbri, A.
Mancuso, S.
Sartori, R.
Storti, S.
Luminari, S.
Mammi, C.
Marcheselli, L.
Arcari, A.
Cavallo, F.
Zilioli, V. R.
Bottelli, C.
Re, A.
Gini, G.
Cox, M. C.
Puccini, B.
Balzarotti, M.
Spina, M.
Rossi, G.
Tucci, A.
HAEMATOLOGICA, 2021, 106 (10) : 56 - 56

← 1 2 3 4 5 →